CergenX secures extra €1.2m for AI-based baby brain scanning software

UCC spinout company has developed a technology that can more easily test for brain abnormalities in newborn babies

Jason Mowles, chief executive, Prof Geraldine Boylan, chief sales officer, and Sean Griffin, chief technology officer, at CergenX, the Cork medtech firm. Picture: David Jones